When it comes to disseminating up-to-date regulated product information to patients and healthcare professionals, electronic product information is the future. But how can the European pharmaceutical industry rise to this challenge?
After years of talk, regulatory bodies worldwide are taking a significant interest in paperless processes and documentation such as electronic product information (ePI) for pharmaceutical companies. In addition to increased efficiency for regulatory systems, ePI will also transform how patients and healthcare professionals interact with the industry.
For more details, download White Paper here: